Jacobs Levy Equity Management’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
SCM
FIS
VCM
Jacobs Levy Equity Management's REPL Position: Q1 2026 in Review
Jacobs Levy Equity Management opened a new position in Replimune Group (REPL) in Q1 2026: 23,199 shares worth $177K. The stake represents ﹤0.01% of the portfolio and ranks #923 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in REPL as recently as Q3 2024.
Jacobs Levy Equity Management first reported a position in REPL in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.09M in Q1 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.
- Jacobs Levy Equity Management held 23,199 shares of Replimune Group worth $177K as of Q1 2026.
- Replimune Group was a new Jacobs Levy Equity Management position in Q1 2026.
- Replimune Group made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #923 holding.
- Jacobs Levy Equity Management first reported a position in Replimune Group in Q1 2024 and has held it in 4 quarters since.
- Jacobs Levy Equity Management's Replimune Group position peaked at $1.09M in Q1 2024.
- 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.